ArticleFuture oncology (London, England)2022

A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an

Raj Satkunasivam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.